Washington State University and Mayo Clinic researchers have developed an electrochemical catheter hub that could someday ...

Table 1. The Bottom Line: Recommendations and Areas of Uncertainty for the Management of CLABSI in Children Diagnosis. Blood cultures should be collected from at least 2 sites before initiation of ...

Getting to zero: impact of a device to reduce blood culture contamination and false-positive central line-associated blood stream infections. Infect Control Hosp Epidemiol. 2022;1-5. doi:10.1017 ...

Getting to zero: impact of a device to reduce blood culture contamination and false-positive central line-associated blood stream infections. Infect Control Hosp Epidemiol. 2022;1-5. doi:10.1017 ...

A retrospective analysis of 1,617 patients with hematologic malignancies admitted and discharged from the Hospital of the University of Pennsylvania during 3,629 encounters from 2017 to 2019 was ...

CorMedix Inc. announces FDA approval of DefenCath® to reduce the incidence of catheter-related bloodstream infections in adult hemodialysis patients. News release. CorMedix Inc. November 15, 2023.

Getting to zero: impact of a device to reduce blood culture contamination and false-positive central line-associated blood stream infections. Infect Control Hosp Epidemiol. 2022;1-5. doi:10.1017 ...

Central Line–Associated Bloodstream Infection in Patients With Hematologic Malignancy Receiving Parenteral Nutrition. JCO Oncol Pract 19 , 571-576 (2023). DOI: 10.1200/OP.22.00823 ...

Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device® (ISDD®) technology, today announced groundbreaking new findings from an in-vitro study demonstrating that ...